HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 19,500
+440 (2.31%)
At close: Aug 20, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 271.82 billion as of August 20, 2026. Its market cap has increased by 167.99% in one year.
Market Cap
271.82B
Enterprise Value
293.96B
Revenue
124.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
19,500.00
ChartMarket Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 271.82B, an increase of 454.68%. That is a compound annual growth rate of 10.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 278.10B | -26.38% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 426.20B |
| Curocell | 398.19B |
| IntoCell | 334.24B |
| IMBiologics | 281.72B |
| Kangstem Biotech | 272.29B |
| curacle co.,ltd. | 260.33B |
| S.Biomedics | 252.66B |
| Genome & Company | 241.62B |